2025年6月7日 周六
Home > Archive>Volume 26, Issue 9, 2018 >936-940
PDF HTML XML Export Cite reminder
The relationship between nonalcoholic fatty liver disease and contrast-induced nephropathy in patients with acute myocardial infarction undergoing percutaneous coronary intervention
Author:
Affiliation:

1.Cardiac Center, Third Central Hospital of Tianjin, Tianjin 300170, China;2.Cardiovascular Research Center, Third Central Hospital of Tianjin, Tianjin 300170, China;3.Tianjin Key Laboratory of Artificial Cell, Tianjin 300170, China;4.Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin 300170, China)

Clc Number:

R5

  • Article
    • | |
  • Metrics
    • |
  • Reference [25]
    • | | | |
  • Comments
    Abstract:

    Aim To investigate the relationship between nonalcoholic fatty liver disease (NAFLD) and contrast-induced nephropathy (CIN) in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI). Methods A total of 261 consecutive patients with acute myocardial infarction undergoing PCI in our hospital from March 2014 to May 2016 were enrolled in this study. Patients were divided into NAFLD group (n＝117) and non-NAFLD group (n＝144) based on the diagnosis of B-mode ultrasound. CIN was defined as≥44.2 μmol/L or ≥25％ increase from baseline serum creatinine within 48～72 hours after contrast medium exposure, and that was not attributable to other causes. The following data were recorded:the baseline measurements, blood urea nitrogen, serum creatinine levels before PCI and 1,2 and 3 days after PCI, estimated glomerular filtration rate (eGFR), the contrast volume and coronary pathological features after PCI. Risk factors for CIN were determined by multivariate Logistic regression analysis. Results CIN occurred in 16.5% (43/261) of patients, and incidence of CIN was significantly higher in the NAFLD group than that in the non-NAFLD group [23.93%(28/117) vs. 10.42% (15/144), P＝0.003]. Compared with adverse events in the hospital, the incidence of acute heart failure in NAFLD group was higher (P＜0.05). Multivariate Logistic regressive analysis showed that NAFLD (OR＝2.18), diabetes (OR＝2.42), contrast volume (OR＝2.44) were risk factors for the incidence of CIN. Conclusion NAFLD is the independent risk predictor of CIN in patients with AMI undergoing PCI.

    Reference
    [1] Marenzi G, Cabiati A, Milazzo V, et al.Contrast-induced nephropathy.Intern Emeg Med, 2,0:181-183.
    [2] 刘晓刚, 刘玉峰, 顾晔, 等.红细胞分布宽度预测2型糖尿病患者对比剂肾病.中国动脉硬化杂志, 6,4(8):837-839.
    [3] Ozcan OU, Er HA, Gulec S, et al.Impact of metabolic syndromeon development of contrast-induced nephropathy after elective percutaneous coronary intervention among nondiabetic patients.Clin Cardiol, 5,8(3):150-156.
    [4] Yki-Jrvinen H.Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.Lancet Diabetes Endocrinol, 4,2:901-910.
    [5] Sayki Arslan M, Turhan S, Dincer I.A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with non-alcoholic fatty liver disease.Diabetol Metab Syndr, 4,6:109-115.
    [6] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南.中华肝脏病杂志, 6,4:161-163.
    [7] Atanda AC, Olafiranye O.Contrast-induced acute kidney injury in interventional cardiology:Emerging evidence and unifying mechanisms of protection by remote ischemic conditioning.Cardiovasc Revasc Med, 7,8(7):549-553.
    [8] 范继红, 胡桃红, 贺威, 等.肾功能正常或轻度损害的急性冠状动脉综合征患者经皮冠状动脉介入治疗术后发生对比剂肾病的危险因素分析.中国循环杂志, 6,1:31-35.
    [9] 张帆, 黄一沁, 保志军.非酒精性脂肪性肝病在我国城市地区的流行现状.中华肝病杂志, 4,4(6):430-432.
    [10] Rinella ME.Nonalcoholic fatty liver disease:a systematic review.JAMA, 5,3(22):2263-2273.
    [11] European Association for the Study of the Liver(EASL), European Association for the Study of Diabetes(EASD), European Association for the Study of Obesity (EASO).EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease.J Hepatol, 6,4(6):1388-1402.
    [12] 杨蕊旭, 范建高.非酒精性脂肪性肝病的流行现状.临床内科杂志, 5,2(5):293-296.
    [13] Targher G, Mantovani A, Pichiri I, et al.Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with Type 2 diabetes.Clin Sci, 3,5:301-309.
    [14] Targher G, Byrne CD.Non-alcoholic fatty liver disease:an emerging driving force in chronic kidney disease.Nat Rev Nephrol, 7,3(5):297-310.
    [15] Kumar PA, Chitra PS, Reddy GB.Metabolic syndrome and associated chronic kidney diseases:nutritional interventions.Rev Endocr Metab Disord, 3,4:273-286.
    [16] Ejerblad E, Fored CM, Lindblad P, et al.Obesity and risk for chronic renal failure.J Am Soc Nephrol, 6,7:1695-1702.
    [17] Abrass CK.Cellular lipid metabolism and the role of lipids in progressive renal disease.Am J Nephrol, 4,4:46-53.
    [18] Valbusa F, Bonapace S, Grillo C, et al.Nonalcoholic fatty liver disease is associated with higher 1-year all-cause rehospitalization rates in patients admitted for acute heart failure.Medicine, 6,5(7):e2760.
    [19] Valbusa F, Bonapace S, Agnoletti D, et al.Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure.PLoS One, 7,2(3):e0173398.
    [20] Emre A, Terzi S, Celiker E, et al.Impact of nonalcoholic fatty liver disease on myocardial perfusion in nondiabetic patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.Am J Cardiol, 5,6:1810-1814.
    [21] Lazaros G, Tsiachris D, Tousoulis D, et al.In-hospital worsening renal function is an independent predictor of one-year mortality in patients with acute myocardial infarction.Int J Cardiol, 2,5:97-101.
    [22] Marcuccilli M, Chonchol M.NAFLD and chronic kidney disease.Int J Mol Sci, 6,7(4):562.
    [23] Fornoni A, Merscher S, Kopp JB.Lipid biology of the podocyte-New perspectives offer new opportunities.Nat Rev Nephrol, 4,0(7):379-388.
    [24] Musso G, Cassader M, Cohney S, et al.Emerging liver-kidney interactions in nonalcoholic fatty liver disease.Trends Mol Med, 5,1:645-662.
    [25] Perticone M, Cimellaro A, Maio R, et al.Additive effect of non-alcoholic fatty liver disease on metabolic syndrome-related endothelial dysfunction in hypertensive patients.Int J Mol Sci, 6,7:456.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

LANG Yuheng, LI Tong, CUI Xiaoqiong, HU Xiaomin, LIU Yingwu, ZHOU Quan, WU Peng, NING Meng, DONG Zhihuan, GAO Zheng. The relationship between nonalcoholic fatty liver disease and contrast-induced nephropathy in patients with acute myocardial infarction undergoing percutaneous coronary intervention[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2018,26(9):936-940.

Copy
Share
Article Metrics
  • Abstract:1446
  • PDF: 725
  • HTML: 0
  • Cited by: 0
History
  • Received:December 18,2017
  • Revised:February 13,2018
  • Online: October 16,2018
Article QR Code

You are the 55643 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025